Biology of factor XI

2.

Rosenthal

RL

,

Dreskin

OH

,

Rosenthal

N

.

New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor

.

Proc Soc Exp Biol Med

.

1953

;

82

(

1

):

171

-

174

.

3.

Jayakrishnan

T

,

Shah

D

,

Mewawalla

P

.

A case report with updates on diagnosis and management of a rare bleeding disorder

.

J Hematol

.

2019

;

8

(

3

):

144

-

147

.

4.

Joseph

K

,

Kaplan

AP

.

Formation of bradykinin: a major contributor to the innate inflammatory response

.

Adv Immunol

.

2005

;

86

:

159

-

208

.

5.

Mohammed

BM

,

Matafonov

A

,

Ivanov

I

, et al.

An update on factor XI structure and function

.

Thromb Res

.

2018

;

161

:

94

-

105

.

6.

Emsley

J

,

McEwan

PA

,

Gailani

D

.

Structure and function of factor XI

.

Blood

.

2010

;

115

(

13

):

2569

-

2577

.

7.

Shearin

S

,

Venkateswarlu

D

.

Structural insights into the activation of blood coagulation factor XI zymogen by thrombin: a computational molecular dynamics study

.

Biophys Chem

.

2022

;

281

:

106737

.

8.

Papagrigoriou

E

,

McEwan

PA

,

Walsh

PN

,

Emsley

J

.

Crystal structure of the factor XI zymogen reveals a pathway for transactivation

.

Nat Struct Mol Biol

.

2006

;

13

(

6

):

557

-

558

.

9.

Gailani

D

,

Smith

SB

.

Structural and functional features of factor XI

.

J Thromb Haemost

.

2009

;

7

(

suppl 1

):

75

-

78

.

10.

Samuel

D

,

Cheng

H

,

Riley

PW

, et al.

Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation

.

Proc Natl Acad Sci U S A

.

2007

;

104

(

40

):

15693

-

15698

.

https://doi.org/10.1055/s-0043-1764469.

11.

Lira

AL

,

Kohs

TCL

,

Moellmer

SA

,

Shatzel

JJ

,

McCarty

OJT

,

Puy

C

.

Substrates, cofactors, and cellular targets of coagulation factor XIa

.

Semin Thromb Hemost

.

Published online 20 March 2023

12.

Renne

T

,

Gailani

D

,

Meijers

JC

,

Muller-Esterl

W

.

Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein

.

J Biol Chem

.

2002

;

277

(

7

):

4892

-

4899

.

13.

Kravtsov

DV

,

Matafonov

A

,

Tucker

EI

, et al.

Factor XI contributes to thrombin generation in the absence of factor XII

.

Blood

.

2009

;

114

(

2

):

452

-

458

.

14.

Baglia

FA

,

Walsh

PN

.

A binding site for thrombin in the apple 1 domain of factor XI

.

J Biol Chem

.

1996

;

271

(

7

):

3652

-

3658

.

15.

Baglia

FA

,

Jameson

BA

,

Walsh

PN

.

Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86

.

J Biol Chem

.

1990

;

265

(

7

):

4149

-

4154

.

16.

Baglia

FA

,

Jameson

BA

,

Walsh

PN

.

Fine mapping of the high molecular weight kininogen binding site on blood coagulation factor XI through the use of rationally designed synthetic analogs

.

J Biol Chem

.

1992

;

267

(

6

):

4247

-

4252

.

17.

Wong

SS

,

Ostergaard

S

,

Hall

G

, et al.

A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain

.

Blood

.

2016

;

127

(

23

):

2915

-

2923

.

18.

Li

C

,

Barroeta

AB

,

Wong

SS

, et al.

Structures of factor XI and prekallikrein bound to domain 6 of high molecular weight kininogen reveals alternate domain 6 conformations and exosites

.

J Thromb Haemost

.

2023

;

21

(

9

):

2378

-

2389

.

19.

Cheng

Q

,

Tucker

EI

,

Pine

MS

, et al.

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

.

Blood

.

2010

;

116

(

19

):

3981

-

3989

.

20.

Sun

MF

,

Zhao

M

,

Gailani

D

.

Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX

.

J Biol Chem

.

1999

;

274

(

51

):

36373

-

36378

.

21.

Ho

DH

,

Baglia

FA

,

Walsh

PN

.

Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain

.

Biochemistry

.

2000

;

39

(

2

):

316

-

323

.

22.

Baglia

FA

,

Gailani

D

,

Lopez

JA

,

Walsh

PN

.

Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI

.

J Biol Chem

.

2004

;

279

(

44

):

45470

-

45476

.

23.

Baglia

FA

,

Shrimpton

CN

,

Emsley

J

, et al.

Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet

.

J Biol Chem

.

2004

;

279

(

47

):

49323

-

49329

.

24.

Bar Barroeta

A

,

Marquart

JA

,

Bakhtiari

K

,

Meijer

AB

,

Urbanus

RT

,

Meijers

JCM

.

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

.

J Thromb Haemost

.

2022

;

20

(

11

):

2538

-

2549

.

25.

Matafonov

A

,

Cheng

Q

,

Geng

Y

, et al.

Evidence for factor IX-independent roles for factor XIa in blood coagulation

.

J Thromb Haemost

.

2013

;

11

(

12

):

2118

-

2127

.

26.

Ho

DH

,

Badellino

K

,

Baglia

FA

,

Walsh

PN

.

A binding site for heparin in the apple 3 domain of factor XI

.

J Biol Chem

.

1998

;

273

(

26

):

16382

-

16390

.

27.

Zhao

M

,

Abdel-Razek

T

,

Sun

MF

,

Gailani

D

.

Characterization of a heparin binding site on the heavy chain of factor XI

.

J Biol Chem

.

1998

;

273

(

47

):

31153

-

31159

.

28.

Morla

S

,

Deguchi

H

,

Zilberman-Rudenko

J

, et al.

Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation

.

J Biol Chem

.

2022

;

298

(

2

):

101567

.

29.

Puy

C

,

Tucker

EI

,

Wong

ZC

, et al.

Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates

.

J Thromb Haemost

.

2013

;

11

(

7

):

1341

-

1352

.

30.

Wu

W

,

Sinha

D

,

Shikov

S

, et al.

Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa

.

J Biol Chem

.

2008

;

283

(

27

):

18655

-

18664

.

31.

Geng

Y

,

Verhamme

IM

,

Smith

SB

, et al.

The dimeric structure of factor XI and zymogen activation

.

Blood

.

2013

;

121

(

19

):

3962

-

3969

.

32.

Yang

L

,

Sun

MF

,

Gailani

D

,

Rezaie

AR

.

Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor

.

Biochemistry

.

2009

;

48

(

7

):

1517

-

1524

.

33.

Rezaie

AR

,

Sun

MF

,

Gailani

D

.

Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity

.

Biochemistry

.

2006

;

45

(

31

):

9427

-

9433

.

34.

Gailani

D

,

Broze

GJ

.

Factor XI activation in a revised model of blood coagulation

.

Science

.

1991

;

253

(

5022

):

909

-

912

.

35.

Naito

K

,

Fujikawa

K

.

Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces

.

J Biol Chem

.

1991

;

266

(

12

):

7353

-

7358

.

36.

Lakshmanan

HHS

,

Estonilo

A

,

Reitsma

SE

, et al.

Revised model of the tissue factor pathway of thrombin generation: role of the feedback activation of FXI

.

J Thromb Haemost

.

2022

;

20

(

6

):

1350

-

1363

.

37.

Factor XI Gene (F11) Variant Database

. Accessed 20 September 2023. https://www.factorxi.org/.

38.

Harris

VA

,

Lin

W

,

Perkins

SJ

.

Analysis of 272 genetic variants in the upgraded interactive FXI web database reveals new insights into FXI deficiency

.

TH Open

.

2021

;

5

(

4

):

e543

-

e556

.

39.

Zivelin

A

,

Bauduer

F

,

Ducout

L

, et al.

Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene

.

Blood

.

2002

;

99

(

7

):

2448

-

2454

.

40.

Esteban

J

,

de la Morena-Barrio

ME

,

Salloum-Asfar

S

, et al.

High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: results from the Yecla study

.

Haemophilia

.

2017

;

23

(

6

):

e488

-

e496

.

41.

Hill

M

,

McLeod

F

,

Franks

H

,

Gordon

B

,

Dolan

G

.

Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion

.

Br J Haematol

.

2005

;

129

(

6

):

825

-

829

.

42.

Shao

Y

,

Cao

Y

,

Lu

Y

, et al.

Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China

.

Blood Cells Mol Dis

.

2016

;

58

:

29

-

34

.

43.

Zucker

M

,

Zivelin

A

,

Landau

M

, et al.

Characterization of seven novel mutations causing factor XI deficiency

.

Haematologica

.

2007

;

92

(

10

):

1375

-

1380

.

44.

gnomAD browser

. Accessed 20 September 2023. https://gnomad.broadinstitute.org/gene/ENSG00000088926?dataset=gnomad_r2_1.

45.

Wiewel-Verschueren

S

,

Mulder

AB

,

Meijer

K

,

Mulder

R

.

Factor 11 single-nucleotide variants in women with heavy menstrual bleeding

.

J Obstet Gynaecol

.

2017

;

37

(

7

):

912

-

918

.

46.

O'Connell

NM

,

Saunders

RE

,

Lee

CA

,

Perry

DJ

,

Perkins

SJ

.

Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling

.

J Thromb Haemost

.

2005

;

3

(

1

):

127

-

138

.

47.

Tiscia

GL

,

Favuzzi

G

,

Lupone

MR

, et al.

Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship

.

Hum Genome Var

.

2017

;

4

:

17043

.

48.

Saunders

RE

,

Shiltagh

N

,

Gomez

K

, et al.

Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency

.

Thromb Haemost

.

2009

;

102

(

2

):

287

-

301

.

49.

Jayandharan

G

,

Shaji

RV

,

Nair

SC

,

Chandy

M

,

Srivastava

A

.

Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val)

.

J Thromb Haemost

.

2005

;

3

(

4

):

808

-

811

.

50.

Castaman

G

,

Giacomelli

SH

,

Habart

D

,

Asselta

R

,

Duga

S

,

Rodeghiero

F

.

Factor XI gene mutations in factor XI deficient patients of the Czech Republic

.

Am J Hematol

.

2008

;

83

(

12

):

916

-

919

.

51.

Ponczek

MB

.

High molecular weight kininogen: a review of the structural literature

.

Int J Mol Sci

.

2021

;

22

(

24

):

13370

.

52.

Singh

PK

,

Chen

ZL

,

Horn

K

,

Norris

EH

.

Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms

.

Res Pract Thromb Haemost

.

2022

;

6

(

7

):

e12815

.

53.

Chen

ZL

,

Singh

PK

,

Horn

K

, et al.

Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo

.

Blood Adv

.

2023

;

7

(

7

):

1156

-

1167

.

54.

Ivanov

I

,

Shakhawat

R

,

Sun

MF

, et al.

Nucleic acids as cofactors for factor XI and prekallikrein activation: different roles for high-molecular-weight kininogen

.

Thromb Haemost

.

2017

;

117

(

4

):

671

-

681

.

55.

Silasi

R

,

Keshari

RS

,

Lupu

C

, et al.

Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death

.

Blood Adv

.

2019

;

3

(

4

):

658

-

669

.

56.

Leung

PY

,

Hurst

S

,

Berny-Lang

MA

, et al.

Inhibition of factor XII-mediated activation of factor XI provides protection against experimental acute ischemic stroke in mice

.

Transl Stroke Res

.

2012

;

3

(

3

):

381

-

389

.

57.

Lorentz

CU

,

Verbout

NG

,

Cao

Z

, et al.

Factor XI contributes to myocardial ischemia-reperfusion injury in mice

.

Blood Adv

.

2018

;

2

(

2

):

85

-

88

.

58.

Ngo

ATP

,

Jordan

KR

,

Mueller

PA

, et al.

Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice

.

J Thromb Haemost

.

2021

;

19

(

4

):

1001

-

1017

.

59.

Kohs

TCL

,

Fallon

ME

,

Oseas

EC

, et al.

Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice

.

Metab Brain Dis

.

2023

;

38

(

7

):

2383

-

2391

.

60.

Lorentz

CU

,

Tucker

EI

,

Verbout

NG

, et al.

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

.

Blood

.

2021

;

138

(

22

):

2173

-

2184

.

61.

Sun

Y

,

Gailani

D

.

Identification of a factor IX binding site on the third apple domain of activated factor XI

.

J Biol Chem

.

1996

;

271

(

46

):

29023

-

29028

.

62.

Geng

Y

,

Verhamme

IM

,

Sun

MF

,

Bajaj

SP

,

Emsley

J

,

Gailani

D

.

Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa

.

J Thromb Haemost

.

2013

;

11

(

7

):

1374

-

1384

.

63.

Choi

SH

,

Smith

SA

,

Morrissey

JH

.

Polyphosphate is a cofactor for the activation of factor XI by thrombin

.

Blood

.

2011

;

118

(

26

):

6963

-

6970

.

64.

Geng

Y

,

Verhamme

IM

,

Smith

SA

, et al.

Factor XI anion-binding sites are required for productive interactions with polyphosphate

.

J Thromb Haemost

.

2013

;

11

(

11

):

2020

-

2028

.

65.

Puy

C

,

Tucker

EI

,

Matafonov

A

, et al.

Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor

.

Blood

.

2015

;

125

(

9

):

1488

-

1496

.

66.

Tucker

EI

,

Marzec

UM

,

White

TC

, et al.

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

.

Blood

.

2009

;

113

(

4

):

936

-

944

.

67.

Blenner

MA

,

Dong

X

,

Springer

TA

.

Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib

.

J Biol Chem

.

2014

;

289

(

9

):

5565

-

5579

.

68.

Berny

MA

,

White

TC

,

Tucker

EI

, et al.

Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist

.

Arterioscler Thromb Vasc Biol

.

2008

;

28

(

2

):

329

-

334

.

69.

Reitsma

SE

,

Pang

J

,

Raghunathan

V

, et al.

Role of platelets in regulating activated coagulation factor XI activity

.

Am J Physiol Cell Physiol

.

2021

;

320

(

3

):

C365

-

C374

.

70.

Kossmann

S

,

Lagrange

J

,

Jackel

S

, et al.

Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension

.

Sci Transl Med

.

2017

;

9

(

375

):

eaah4923

.

71.

Kohs

TC

,

Vu

HH

,

Jordan

KR

, et al.

Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia

.

Res Pract Thromb Haemost

.

2023

;

8

(

1

). 102276.

72.

Cheng

Q

,

Sun

MF

,

Kravtsov

DV

,

Aktimur

A

,

Gailani

D

.

Factor XI apple domains and protein dimerization

.

J Thromb Haemost

.

2003

;

1

(

11

):

2340

-

2347

.

73.

van Montfoort

ML

,

Knaup

VL

,

Marquart

JA

, et al.

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model

.

Thromb Haemost

.

2013

;

110

(

5

):

1065

-

1073

.

74.

Al-Horani

RA

,

Desai

UR

.

Factor XIa inhibitors: a review of the patent literature

.

Expert Opin Ther Pat

.

2016

;

26

(

3

):

323

-

345

.

75.

Wolberg

AS

,

Morris

DP

,

Stafford

DW

.

Factor IX activation by factor XIa proceeds without release of a free intermediate

.

Biochemistry

.

1997

;

36

(

14

):

4074

-

4079

.

76.

Gailani

D

,

Geng

Y

,

Verhamme

I

, et al.

The mechanism underlying activation of factor IX by factor XIa

.

Thromb Res

.

2014

;

133

(

suppl 1

):

S48

-

51

.

77.

Whelihan

MF

,

Orfeo

T

,

Gissel

MT

,

Mann

KG

.

Coagulation procofactor activation by factor XIa

.

J Thromb Haemost

.

2010

;

8

(

7

):

1532

-

1539

.

78.

Puy

C

,

Tucker

EI

,

Ivanov

IS

, et al.

Platelet-derived short-chain polyphosphates enhance the inactivation of tissue factor pathway inhibitor by activated coagulation factor XI

.

PLoS One

.

2016

;

11

(

10

):

e0165172

.

79.

Garland

KS

,

Reitsma

SE

,

Shirai

T

, et al.

Removal of the C-terminal domains of ADAMTS13 by activated coagulation factor XI induces platelet adhesion on endothelial cells under flow conditions

.

Front Med

.

2017

;

4

:

232

.

80.

Bane

CE

,

Ivanov

I

,

Matafonov

A

, et al.

Factor XI deficiency alters the cytokine response and activation of contact proteases during polymicrobial sepsis in mice

.

PLoS One

.

2016

;

11

(

4

):

e0152968

.

81.

Scott

CF

,

Silver

LD

,

Purdon

AD

,

Colman

RW

.

Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function

.

J Biol Chem

.

1985

;

260

(

19

):

10856

-

10863

.

82.

Puy

C

,

Pang

J

,

Reitsma

SE

, et al.

Cross-talk between the complement pathway and the contact activation system of coagulation: activated factor XI neutralizes complement factor H

.

J Immunol

.

2021

;

206

(

8

):

1784

-

1792

.

83.

Shi

T

,

Giannakopoulos

B

,

Iverson

GM

,

Cockerill

KA

,

Linnik

MD

,

Krilis

SA

.

Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318

.

J Biol Chem

.

2005

;

280

(

2

):

907

-

912

.

84.

Heal

SL

,

Hardy

LJ

,

Wilson

CL

, et al.

Novel interaction of properdin and coagulation factor XI: crosstalk between complement and coagulation

.

Res Pract Thromb Haemost

.

2022

;

6

(

4

):

e12715

.

85.

Ge

X

,

Yamaguchi

Y

,

Zhao

L

, et al.

Prochemerin cleavage by factor XIa links coagulation and inflammation

.

Blood

.

2018

;

131

(

3

):

353

-

364

.

86.

Peek

M

,

Moran

P

,

Mendoza

N

,

Wickramasinghe

D

,

Kirchhofer

D

.

Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa

.

J Biol Chem

.

2002

;

277

(

49

):

47804

-

47809

.

87.

Knauer

DJ

,

Majumdar

D

,

Fong

PC

,

Knauer

MF

.

SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor

.

J Biol Chem

.

2000

;

275

(

48

):

37340

-

37346

.

88.

Yi

BA

,

Freedholm

D

,

Widener

N

, et al.

Pharmacokinetics and pharmacodynamics of abelacimab (MAA868), a novel dual inhibitor of factor XI and factor XIa

.

J Thromb Haemost

.

2022

;

20

(

2

):

307

-

315

.

89.

Verhamme

P

,

Yi

BA

,

Segers

A

, et al.

Abelacimab for prevention of venous thromboembolism

.

N Engl J Med

.

2021

;

385

(

7

):

609

-

617

.

90.

Schaefer

M

,

Buchmueller

A

,

Dittmer

F

,

Straßburger

J

,

Wilmen

A

.

Allosteric inhibition as a new mode of action for BAY 1213790, a neutralizing antibody targeting the activated form of coagulation factor XI

.

J Mol Biol

.

2019

;

431

(

24

):

4817

-

4833

.

91.

Zilberman-Rudenko

J

,

Itakura

A

,

Wiesenekker

CP

, et al.

Coagulation factor XI promotes distal platelet activation and single platelet consumption in the bloodstream under shear flow

.

Arterioscler Thromb Vasc Biol

.

2016

;

36

(

3

):

510

-

517

.

92.

Piccini

JP

,

Caso

V

,

Connolly

SJ

, et al.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

.

Lancet

.

2022

;

399

(

10333

):

1383

-

1390

.

93.

Rao

SV

,

Kirsch

B

,

Bhatt

DL

, et al.

A multicenter, phase 2, randomized, placebo-controlled, double-blind, parallel-group, dose-finding trial of the oral factor XIa inhibitor asundexian to prevent adverse cardiovascular outcomes after acute myocardial infarction

.

Circulation

.

2022

;

146

(

16

):

1196

-

1206

.

94.

Cao

Y

,

Wang

Y

,

Zhou

Z

, et al.

Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure

.

Science

.

2022

;

377

(

6613

):

1399

-

1406

.

95.

Gailani

D

,

Schmidt

A

,

Sun

MF

,

Bolton-Maggs

PH

,

Bajaj

SP

.

A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect

.

J Thromb Haemost

.

2007

;

5

(

4

):

781

-

787

.

96.

Puy

C

,

Rigg

RA

,

McCarty

OJ

.

The hemostatic role of factor XI

.

Thromb Res

.

2016

;

141

(

suppl 2

):

S8

-

S11

.

97.

Zucker

M

,

Seligsohn

U

,

Salomon

O

,

Wolberg

AS

.

Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency

.

J Thromb Haemost

.

2014

;

12

(

7

):

1121

-

1130

.